Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Lysosomes as a therapeutic target
SR Bonam, F Wang, S Muller - Nature reviews Drug discovery, 2019 - nature.com
Lysosomes are membrane-bound organelles with roles in processes involved in degrading
and recycling cellular waste, cellular signalling and energy metabolism. Defects in genes …
and recycling cellular waste, cellular signalling and energy metabolism. Defects in genes …
Exploring pro-inflammatory immunological mediators: Unraveling the mechanisms of neuroinflammation in lysosomal storage diseases
MK Pandey - Biomedicines, 2023 - mdpi.com
Lysosomal storage diseases are a group of rare and ultra-rare genetic disorders caused by
defects in specific genes that result in the accumulation of toxic substances in the lysosome …
defects in specific genes that result in the accumulation of toxic substances in the lysosome …
GM1 gangliosidosis type II: Results of a 10-year prospective study
Abstract Purpose GM1 gangliosidosis (GM1) a lysosomal disorder caused by pathogenic
variants in GLB1, is characterized by relentless neurodegeneration. There are no approved …
variants in GLB1, is characterized by relentless neurodegeneration. There are no approved …
[HTML][HTML] GLB1-related disorders
DS Regier, CJ Tifft, CE Rothermel - 2021 - europepmc.org
GLB1-related disorders comprise two phenotypically distinct lysosomal storage disorders:
GM1 gangliosidosis and mucopolysaccharidosis type IVB (MPS IVB). The phenotype of GM1 …
GM1 gangliosidosis and mucopolysaccharidosis type IVB (MPS IVB). The phenotype of GM1 …
The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis
FM Lang, P Korner, M Harnett, A Karunakara… - Molecular genetics and …, 2020 - Elsevier
Introduction Type 1 GM1 gangliosidosis is an ultra-rare, rapidly fatal lysosomal storage
disorder, with life expectancy of< 3 years of age. To date, only one prospective natural …
disorder, with life expectancy of< 3 years of age. To date, only one prospective natural …
The clinical and molecular spectrum of GM1 gangliosidosis
L Arash-Kaps, K Komlosi, M Seegräber… - The Journal of …, 2019 - Elsevier
Objective To evaluate the clinical presentation of patients with GM1 gangliosidosis and to
determine whether specific clinical or biochemical signs could lead to a prompt diagnosis …
determine whether specific clinical or biochemical signs could lead to a prompt diagnosis …
A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy
S Liu, Y Feng, Y Huang, X Jiang… - Experimental …, 2021 - journals.sagepub.com
GM1 gangliosidosis is a rare lysosomal storage disease caused by a deficiency of β-
galactosidase due to mutations in the GLB1 gene. We established a C57BL/6 mouse model …
galactosidase due to mutations in the GLB1 gene. We established a C57BL/6 mouse model …
[HTML][HTML] The juvenile gangliosidoses: A timeline of clinical change
Background The gangliosidoses are rare inherited diseases that result in pathologic
accumulation of gangliosides in the central nervous system and other tissues, leading to …
accumulation of gangliosides in the central nervous system and other tissues, leading to …
Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
R Tonin, A Caciotti, E Procopio, R Fischetto… - Scientific Reports, 2019 - nature.com
GM1 ganglioside, a monosialic glycosphingolipid and a crucial component of plasma
membranes, accumulates in lysosomal storage disorders, primarily in GM1 gangliosidosis …
membranes, accumulates in lysosomal storage disorders, primarily in GM1 gangliosidosis …
Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes
Background In this study, the prevalence of different types of mucopolysaccharidoses (MPS)
was estimated based on data from the exome aggregation consortium (ExAC) and the …
was estimated based on data from the exome aggregation consortium (ExAC) and the …